Sponsored
by Takara Bio
Combination Therapies: Opportunities for Improved CAR-T Cell Therapy?
Chimeric antigen receptor (CAR) cell therapy offers hope where other cancer therapies have failed. However,…
10/03/2022 - 6 minutes
Blood cancer
Gene-Edited T Cell Therapy Players Battle Safety Doubts
Confidence in gene-edited T cell therapies from donor cells has faltered as Allogene Therapeutics paused…
22/10/2021 - 5 minutes
A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
11/10/2021 - 10 minutes
Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents
Update (01/02/2019): MorphoSys has agreed to end its long-running legal battle with Genmab and Janssen, after…
28/01/2019 - 3 minutes
Update: French Biotech Considers Takeover After Failed Leukemia Drug Trial
Update (14/01/2019): An anonymous French company on Euronext has made an offer to take over…
14/01/2019 - 2 minutes
Genmab and Janssen Suffer Combination Therapy Setback
Janssen will discontinue a Phase I study testing Danish biotech Genmab's blood cancer blockbuster daratumumab…
28/05/2018 - 2 minutes
Engineering Red Blood Cells to Fight the Most Severe Cancers
Our very own red blood cells could soon become a treatment for some of the…
21/05/2018 - 6 minutes
“This is the First Time CAR-T Has Ever Worked on Acute Myeloid Leukemia“
Celyad has reported clinical results showing the first time a patient has fully recovered from…
19/04/2018 - 3 minutes
This Spanish Biotech Is Developing Stem-Cell Targeted Leukemia Treatments
This week, we're in Barcelona, Spain, to visit Leukos Biotech, whose goal is to develop…
02/03/2018 - 2 minutes
Novartis Takes Genmab’s Leukemia Drug Off the Market
Genmab's leukemia drug will be available around the world through compassionate use programs, while it will…
22/01/2018 - 3 minutes
Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017
Now that we've got the bad news out of the way, we're here to spread…
18/12/2017 - 9 minutes
Off-the-Shelf CAR-T Cells Struggle to Improve Cancer Treatment
Data presented at ASH 2017 shows that Servier and Pfizer's UCART19, an allogeneic CAR-T therapy…
13/12/2017 - 4 minutes
